ReviewComputational and structural biotechnology journal2026
Cavity-Filling Mutations as a Strategy to Stabilize Prefusion Viral Fusion Proteins for Vaccine Design.
Review in Computational and structural biotechnology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Enveloped viruses use metastable fusion proteins to enter host cells through large-scale conformational rearrangements. The prefusion conformation represents a higher-energy metastable state that irreversibly refolds into a lower-energy postfusion conformation during membrane fusion. Although the prefusion state contains the key neutralizing epitopes, it represents an ideal target for vaccine development. However, because of the instability of the prefusion state, the development of a viable vaccine and the determination of the prefusion state are both major challenges. Building on advances in structure-based vaccine design, cavity-filling mutations have emerged as a promising strategy for stabilizing prefusion viral fusion proteins across viral systems. Cavity-filling mutations have been shown in several viral systems to improve protein stability, thermostability, antigen expression, and immunogenicity. However, these effects depend on the structural architecture, cavity geometry, and local conformational context of each protein. In addition, these modifications may reduce premature transitions to the postfusion conformation and may help preserve critical neutralizing epitopes, depending on the structural context, while maintaining a metastable prefusion state. Accordingly, this review summarizes the molecular basis of cavity-filling-mediated stabilization, highlights successful applications across diverse viral families, examines how structural stabilization influences immunogenicity, and discusses the potential of cavity-filling strategies for rational vaccine design.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.